[av_one_half first min_height=” vertical_alignment=” space=” custom_margin=” margin=’0px’ padding=’0px’ border=” border_color=” radius=’0px’ background_color=” src=” background_position=’top left’ background_repeat=’no-repeat’ animation=” mobile_breaking=” mobile_display=”]
[av_image src=’https://www.ildex-vietnam.com/wp-content/uploads/2022/07/Prof-2-300×300.png’ attachment=’9944′ attachment_size=’medium’ align=’center’ styling=’circle’ hover=” link=” target=” caption=” font_size=” appearance=” overlay_opacity=’0.4′ overlay_color=’#000000′ overlay_text_color=’#ffffff’ animation=’no-animation’ admin_preview_bg=”][/av_image]
[/av_one_half][av_one_half min_height=” vertical_alignment=” space=” custom_margin=” margin=’0px’ padding=’0px’ border=” border_color=” radius=’0px’ background_color=” src=” background_position=’top left’ background_repeat=’no-repeat’ animation=” mobile_breaking=” mobile_display=”]
[av_textblock size=” font_color=” color=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” admin_preview_bg=”]
Topic: “MEFLUVAC™ H5 Plus 8 – A Vaccine To Protect Against Recent HPAI Threats (H5N1, H5N6, H5N8 and more)”
Date: Wednesday, 3 August 2022 | 12:15-13:15 hrs. (GMT +7)
By Prof. Wael Elfeil, Technical Service & Clinical Research Manager, MEVAC
[/av_textblock]
[/av_one_half]
.png){kind=small}